In contrast to the 17-week latency for spontaneous tumor recurrence, doxycycline-induced re-expression of the HER2/neu transgene resulted in recurrent tumor formation at the original sites of primary tumors within 2 weeks in all mice (Additional file 1: Fig. S1f). The gene discussed is ERBB2; the disease is neoplasm.